Sign in
  1. Home
  2. Companies
  3. Citius Pharmaceuticals
  4. Financial Statements
  5. Income Statement
  6. Shares
Citius Pharmaceuticals logo
Citius Pharmaceuticals CTXR
$ 0.55 1.19%
report update icon

Quarterly report 2026-Q2
added 05-15-2026

Citius Pharmaceuticals Shares | CTXR

Annual Shares Citius Pharmaceuticals

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
11.1 M 6.73 M 6.05 M 146 M 109 M 39.2 M 20.2 M 10.7 M 5.48 M 3.62 M 2.12 M 2.12 M - - - 18 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
146 M 2.12 M 29.2 M

Quarterly Shares Citius Pharmaceuticals

2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
22.4 M 21.5 M 21.5 M 18.1 M 11 M 8.58 M 7.49 M 7.25 M 6.95 M 6.36 M 6.36 M 159 M 154 M 146 M 146 M 146 M 146 M 146 M 146 M 96 M 137 M 96 M 55.6 M 35 M 41.6 M 55.6 M 29.2 M 19.4 M 22 M 29.2 M 17.8 M 9.76 M 10.7 M 17.8 M 8.61 M 4.98 M 5.05 M 8.61 M 4.9 M 4.88 M 4.84 M 73.6 M 34.4 M 31.2 M 32.3 M 34.4 M 30 M 17.8 M 18 M 18 M 18 M 18 M 18 M 18 M 18 M 18 M 18 M 18 M 18 M 18 M 18 M 18 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
159 M 4.84 M 41.1 M

Shares of other stocks in the Biotechnology industry

Issuer Shares Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
 		38.7 M - 5743.5 % $ 69.7 M canadaCanada
MorphoSys AG MorphoSys AG
MOR
 		33.4 M - 2.43 % $ 254 M germanyGermany
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
 		4.73 M - 1.35 % $ 17.8 M chinaChina
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
 		130 M - - $ 2.02 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
 		10.2 M - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
 		220 M - - $ 866 M chinaChina
Corner Growth Acquisition Corp. Corner Growth Acquisition Corp.
COOL
 		9.83 M - -0.89 % $ 114 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
 		85.1 M - - $ 2.18 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		219 M - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
 		44.7 B - 2.54 % $ 160 B franceFrance
Biophytis SA Biophytis SA
BPTS
 		543 M - -13.47 % $ 169 M franceFrance
Alpine Immune Sciences Alpine Immune Sciences
ALPN
 		50 M - - $ 2.17 B usaUSA
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited
ASLN
 		192 M - -14.27 % $ 1.7 M singaporeSingapore
AstraZeneca PLC AstraZeneca PLC
AZN
 		1.55 B - - $ 96.9 B britainBritain
CureVac N.V. CureVac N.V.
CVAC
 		224 M - - $ 867 M germanyGermany
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		4.58 M - -1.52 % $ 24.7 M usaUSA
Athira Pharma Athira Pharma
ATHA
 		4.28 M - - $ 269 M usaUSA
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.
BVXV
 		9.34 B - 0.74 % $ 768 M israelIsrael
Abcam plc Abcam plc
ABCM
 		229 M - - $ 4.9 B britainBritain
Galera Therapeutics Galera Therapeutics
GRTX
 		98.5 M - -32.59 % $ 7.61 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		54.9 B - -18.52 % $ 27.3 M britainBritain
Affimed N.V. Affimed N.V.
AFMD
 		120 M - -34.95 % $ 21.5 M germanyGermany
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		75 M - - - russiaRussia
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
 		21.6 M - - $ 231 M usaUSA
Celyad Oncology SA Celyad Oncology SA
CYAD
 		22.6 M - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
 		68.9 M - -7.31 % $ 87 M usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
 		66.6 M - - $ 344 M usaUSA
IMV IMV
IMV
 		8.34 M - - $ 13.1 M canadaCanada
Akero Therapeutics Akero Therapeutics
AKRO
 		67.1 M - - $ 3.67 B usaUSA
Akouos Akouos
AKUS
 		34.4 M - 0.23 % $ 488 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		15.4 M - - $ 7.46 M israelIsrael
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
 		2.19 M - -4.36 % $ 27 M usaUSA
Freeline Therapeutics Holdings plc Freeline Therapeutics Holdings plc
FRLN
 		59.3 M - - $ 384 M britainBritain
Gracell Biotechnologies Gracell Biotechnologies
GRCL
 		338 M - - $ 3.37 B chinaChina
Advaxis Advaxis
ADXS
 		6.02 M - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		3.17 M - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		78.2 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		45 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		14.3 M - 1.93 % $ 17.4 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
 		2.45 M - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
 		67.7 M - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		19.2 M - -0.23 % $ 916 M usaUSA
AlloVir AlloVir
ALVR
 		15.3 M - 4.14 % $ 49.1 M usaUSA
Allakos Allakos
ALLK
 		88.8 M - - $ 28.6 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
 		68 M - 3.16 % $ 1.9 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
 		810 K - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
 		38.8 M - - $ 10.1 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
 		25.4 M - 10.36 % $ 9.8 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
 		140 M - - $ 8.42 M usaUSA
Aravive Aravive
ARAV
 		36.4 M - -13.39 % $ 1.45 M usaUSA